SOPHiA GENETICS and Memorial Sloan Kettering Cancer Center Aim to Establish Precision Medicine Hub for the Next Generation of Precision Oncology NEW YORK — SOPHiA GENETICS (NASDAQ: SOPH) today announced that the company has signed a Memorandum of Understanding (MOU) with Memorial Sloan Kettering Cancer Center (MSK) relating to the formation of a joint venture between the two […]

New conversational AI platform leverages the world’s largest human genetics database to power target discovery and validation. Mystra AI is the market-leading agent, accessible to all scientists in Research & Development and Business Development & Licensing. 95% of drug candidates in clinical trials fail. Targets with human genetic support are 2.6 times more likely to […]

New conversational AI platform leverages the world’s largest human genetics database to power target discovery and validation. Mystra AI is the market-leading agent, accessible to all scientists in Research & Development and Business Development & Licensing. 95% of drug candidates in clinical trials fail. Targets with human genetic support are 2.6 times more likely to […]

Collaboration integrates NVIDIA accelerated computing and the NVIDIA BioNeMo platform with QIAGEN Digital Insights’ curated biomedical knowledge bases Goal to advance how disease mechanisms, therapeutic targets and biomarkers are identified Graph-based AI approach designed to help researchers explore mechanisms, therapeutic targets and biomarkers with greater speed, context and confidence Initial pilot programs available to select […]

OmicsHQ brings together comprehensive, expertly curated, standardized multi-omics datasets from across the scientific ecosystem, complete with pre-processed datasets ready to accelerate research, drug-discovery, and AI-driven innovation. SAN DIEGO — Today Rancho BioSciences, the premier tech-enabled data science partner for biopharma, announced the launch of OmicsHQTM, a unified catalog of expertly curated, standardized multi-omics datasets designed for immediate […]

17-Year Multiomics Pioneer Powers Next Era of Precision Health MOUNTAIN VIEW, Calif. — Today, DNAnexus signals a bold new chapter in AI-powered precision health with several new product innovations and solution packages that extend its position as the purpose-built platform where the world’s most scientifically complex data becomes the world’s most powerful AI fuel. These […]

CAMBRIDGE, Mass. — Quantori, a leading provider of digital transformation services and technology for the life sciences and healthcare industries, today announced a co-marketing partnership with Knowledge3 (K3), a company focused on bridging the gap between business goals and IT delivery through Knowledge Graphs, FAIR data principles, and graph-grounded Generative AI. The partnership brings together Quantori’s […]

New agentic product helps life science teams evaluate, prioritize, and advance higher-confidence product opportunities ahead of major development investment SOUTH SAN FRANCISCO, Calif. — Brightseed, Inc., a bio- and AI-native powered innovation platform for life science teams, today announced the launch of Hummingbird™, a new agentic AI product designed to help teams turn biological discovery […]

Molecular Universe Introduces MU-StarSeeker, an Agent-Managed AI Platform as Part of its Latest Frontier Workflow Automation MU-3.0 Release MU-StarSeeker in MU-3.0 release expands Molecular Universe from AI-assisted research workflow to agent-managed materials discovery automation, from molecule search and formulation optimization to cell performance prediction and manufacturing quality guidance MU-3.0 coverage expands to Sodium-ion (Na-ion) given […]

Scantox completes DuplexSeq™ technology transition, advancing error-corrected sequencing on a scalable cloud-based platform. EJBY, Denmark — Scantox Group today announced the launch of the Scantox DuplexSeq Mutagenesis App, hosted on an upgraded bioinformatics platform for its DuplexSeq™ Mutagenesis Assay kits and services. The launch restores customer access to DuplexSeq™ Mutagenesis Assays on stronger foundations: reagent […]